Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANAGLIFLOZIN\METFORMIN Cause Off label use? 67 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Off label use have been filed in association with CANAGLIFLOZIN\METFORMIN. This represents 4.3% of all adverse event reports for CANAGLIFLOZIN\METFORMIN.

67
Reports of Off label use with CANAGLIFLOZIN\METFORMIN
4.3%
of all CANAGLIFLOZIN\METFORMIN reports
0
Deaths
13
Hospitalizations

How Dangerous Is Off label use From CANAGLIFLOZIN\METFORMIN?

Of the 67 reports, 13 (19.4%) required hospitalization.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANAGLIFLOZIN\METFORMIN. However, 67 reports have been filed with the FAERS database.

What Other Side Effects Does CANAGLIFLOZIN\METFORMIN Cause?

Osteomyelitis (197) Toe amputation (196) Diabetic ketoacidosis (185) Acute kidney injury (105) Cellulitis (92) Diabetic foot infection (85) Gangrene (82) Blood glucose increased (69) Diabetic foot (65) Leg amputation (62)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Which CANAGLIFLOZIN\METFORMIN Alternatives Have Lower Off label use Risk?

CANAGLIFLOZIN\METFORMIN vs CANAKINUMAB CANAGLIFLOZIN\METFORMIN vs CANDESARTAN CANAGLIFLOZIN\METFORMIN vs CANDESARTAN CILEXETIL CANAGLIFLOZIN\METFORMIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE CANAGLIFLOZIN\METFORMIN vs CANGRELOR

Related Pages

CANAGLIFLOZIN\METFORMIN Full Profile All Off label use Reports All Drugs Causing Off label use CANAGLIFLOZIN\METFORMIN Demographics